Savior Lifetec Corporation (TPEX:4167)
20.95
+0.05 (0.24%)
At close: Jul 9, 2026
Savior Lifetec Company Description
Savior Lifetec Corporation engages in the research, development, design, manufacture, and sale of carbapenem generics in the Americas, Asia, Taiwan, Europe, and internationally.
The company offers injection generics, controlled-release generics, the development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms.
It also provides medicine manufacturer technology and services. In addition, the company sells antibacterial raw materials and injectables.
Savior Lifetec Corporation was founded in 1993 and is headquartered in Tainan City, Taiwan.
Savior Lifetec Corporation
| Country | Taiwan |
| Founded | 1993 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 384 |
| CEO | Chih-Fang Chen |
Contact Details
Address: No. 1, Nanke 6th Road Tainan City, 744094 Taiwan | |
| Phone | 886 6 505 1200 |
| Website | saviorlifetec.com.tw |
Stock Details
| Ticker Symbol | 4167 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0004167002 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Chia-Chu Chou | Representative Director and Assistant Vice President |
| Chih-Fang Chen | President and Managerial Officer |
| Kuo-Wei Lin | Financial Officer and Accounting Supervisor |
| Fang Zhen Xu | Head of Internal Audit |